Fabtech TechnologiesNSE:FABTECH -0.18%20 ROE % is 21.02% as of Mar. 2026, which is 24% below its 10-year median of 27.80. GuruFocus rates NSE:FABTECH with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 625 Healthcare Providers & Services companies, Fabtech Technologies ranks worse than 51.36% on this metric.
The historical rank and industry rank for Fabtech Technologies's ROE % or its related term are showing as below:
NSE:FABTECH'
s ROE % Range Over the Past 10 Years
Min: 5.52 Med: 27.8 Max: 34.84
Current: 5.52
During the past 5 years, Fabtech Technologies's highest ROE % was 34.84%. The lowest was 5.52%. And the median was 27.80%.
NSE:FABTECH's ROE % is ranked worse than 51.36% of 625
companies
in the Healthcare Providers & Services industry
Industry Median: 5.84
vs NSE:FABTECH: 5.52
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Fabtech Technologies's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabtech Technologies ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fabtech Technologies's ROE % distribution charts can be found below:
* The bar in red indicates where Fabtech Technologies's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Fabtech Technologies (NSE:FABTECH) has a ROE % of 21.02% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Fabtech Technologies and its competitors. This is 24% below median its historical median of 27.80. Over the past decade, Fabtech Technologies' ROE % has ranged from 5.52 to 34.84. According to the industry distribution chart, Fabtech Technologies ranks #321 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 51.4%.
Is Fabtech Technologies' ROE % too high?
Fabtech Technologies' current ROE % of 21.02% is 24% below median its 10-year median of 27.80. Over the past 10 years, this metric has ranged from a low of 5.52 to a high of 34.84. The Healthcare Providers & Services industry median ROE % is 5.84. Fabtech Technologies' value of 21.02% is 259.9% above this industry median. Based on the distribution chart, Fabtech Technologies ranks #321 out of 625 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fabtech Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Fabtech Technologies' ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Fabtech Technologies ranks #321 out of 625 companies for ROE %. This places Fabtech Technologies in the lower half of its industry. The industry median ROE % is 5.84. Fabtech Technologies' value of 21.02% is 259.9% above this benchmark. Historically, Fabtech Technologies' own ROE % has ranged from 5.52 to 34.84 over the past decade. While the company's 10-year median is 27.80 vs. the industry median of 5.84, Fabtech Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabtech Technologies's current ROE % of 21.02% is 259.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Fabtech Technologies and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabtech Technologies's current ROE % is 21.02%, which is 24% below median its own 10-year median of 27.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabtech Technologies stock overvalued right now?
Fabtech Technologies (NSE:FABTECH) has a current ROE % of 21.02%. The current ROE % is 21.02%, which is 24% below median its 10-year median of 27.80 and 259.9% above the Healthcare Providers & Services industry median of 5.84. Fabtech Technologies' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Fabtech Technologies (NSE:FABTECH), the current ROE % is 21.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fabtech Technologies Ltd is engaged in building pharmaceutical, biotech, and healthcare capabilities for a wide range of customers by offering comprehensive start-to-finish turnkey solutions, which include supplying pharmaceutical machinery/equipment, in-house designing and engineering, procurement, installation, validation, and undertaking other activities required in various projects, including standalone equipment supply and installation. The company provides solutions for clean air, manufacturing processes, purified water and pure steam generation and distribution, etc. The majority of its revenue is generated from the trading of pharmaceutical and surgical products. Geographically, the company derives maximum revenue from international markets, and the rest from its business in India.
20GF Score
Get the complete analysis for NSE:FABTECH
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:FABTECH has been successfully added to your 